|
1
|
Lin JY and Fisher DE: Melanocyte biology
and skin pigmentation. Nature. 445:843–850. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yun WJ, Kim EY, Park JE, Jo SY, Bang SH,
Chang EJ and Chang SE: Microtubule-associated protein light chain 3
is involved in melanogenesis via regulation of MITF expression in
melanocytes. Sci Rep. 6:199142016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner M and Hearing VJ: The protective
role of melanin against UV damage in human skin. Photochem
Photobiol. 84:539–549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fitzpatrick TB and Breathnach AS: The
epidermal melanin unit system. Dermatol Wochenschr. 147:481–489.
1963.(In German). PubMed/NCBI
|
|
5
|
Videira IF, Moura DF and Magina S:
Mechanisms regulating melanogenesis. An Bras Dermatol. 88:76–83.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sharov AA, Fessing M, Atoyan R, Sharova
TY, Haskell-Luevano C, Weiner L, Funa K, Brissette JL, Gilchrest BA
and Botchkarev VA: Bone morphogenetic protein (BMP) signaling
controls hair pigmentation by means of cross-talk with the
melanocortin receptor-1 pathway. Proc Natl Acad Sci USA. 102:93–98.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Halaban R, Rubin JS, Funasaka Y, Cobb M,
Boulton T, Faletto D, Rosen E, Chan A, Yoko K and White W: Met and
hepatocyte growth factor/scatter factor signal transduction in
normal melanocytes and melanoma cells. Oncogene. 7:2195–2206.
1992.PubMed/NCBI
|
|
8
|
Luo D, Chen H, Searles G and Jimbow K:
Coordinated mRNA expression of c-Kit with tyrosinase and TRP-1 in
melanin pigmentation of normal and malignant human melanocytes and
transient activation of tyrosinase by Kit/SCF-R. Melanoma Res.
5:303–309. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Botchkareva NV, Khlgatian M, Longley BJ,
Botchkarev VA and Gilchrest BA: SCF/c-kit signaling is required for
cyclic regeneration of the hair pigmentation unit. FASEB J.
15:645–658. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katz M, Amit I and Yarden Y: Regulation of
MAPKs by growth factors and receptor tyrosine kinases. Biochim
Biophys Acta. 1773:1161–1176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wellbrock C and Arozarena I:
Microphthalmia-associated transcription factor in melanoma
development and MAP-kinase pathway targeted therapy. Pigment Cell
Melanoma Res. 28:390–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zwick E, Bange J and Ullrich A: Receptor
tyrosine kinase signalling as a target for cancer intervention
strategies. Endocr Relat Cancer. 8:161–173. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hubbard SR and Miller WT: Receptor
tyrosine kinases: Mechanisms of activation and signaling. Curr Opin
Cell Biol. 19:117–123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wheeler DL, Iida M and Dunn EF: The role
of Src in solid tumors. Oncologist. 4:667–678. 2009. View Article : Google Scholar
|
|
15
|
Park J, Chung H, Bang SH, Han AR, Seo EK,
Chang SE, Kang DH and Oh ES:
(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol enhances melanogenesis
through increasing upstream stimulating factor-1-mediated
tyrosinase expression. PLoS One. 10:e01419882015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee KE, Lee SK, Jung SE, Lee Zh and Kim
JW: Functional splicing assay of DSPP mutations in hereditary
dentin defects. Oral Dis. 17:690–695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hennessy A, Oh C, Diffey B, Wakamatsu K,
Ito S and Rees J: Eumelanin and pheomelanin concentrations in human
epidermis before and after UVB irradiation. Pigment Cell Res.
18:220–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Niwano T, Terazawa S, Nakajima H and
Imokawa G: The stem cell factor-stimulated melanogenesis in human
melanocytes can be abrogated by interrupting the phosphorylation of
MSK1: Evidence for involvement of the p38/MSK1/CREB/MITF axis. Arch
Dermatol Res. 10:187–196. 2018. View Article : Google Scholar
|
|
20
|
Tatro JB, Atkins M, Mier JW, Hardarson S,
Wolfe H, Smith T, Entwistle ML and Reichlin S: Melanotropin
receptors demonstrated in situ in human melanoma. J Clin Invest.
85:1825–1832. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thody AJ, Hunt G, Donatien PD and Todd C:
Human melanocytes express functional melanocyte-stimulating hormone
receptors. Ann NY Acad Sci. 680:381–390. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hocker TL, Singh MK and Tsao H: Melanoma
genetics and therapeutic approaches in the 21st century: Moving
from the benchside to the bedside. J Invest Dermatol.
128:2575–2595. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Buscà R, Bertolotto C, Ortonne JP and
Ballotti R: Inhibition of the phosphatidylinositol
3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell
differentiation. J Biol Chem. 271:31824–31830. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cheli Y, Ohanna M, Ballotti R and
Bertolotto C: Fifteen-year quest for microphthalmia-associated
transcription factor target genes. Pigment Cell Melanoma Res.
23:27–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kobayashi T, Urabe K, Winder A,
Jiménez-Cervantes C, Imokawa G, Brewington T, Solano F,
García-Borrón JC and Hearing VJ: Tyrosinase related protein 1
(TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO
J. 13:5818–5825. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohguchi K, Akao Y and Nozawa Y:
Involvement of calpain in melanogenesis of mouse B16 melanoma
cells. Mol Cell Biochem. 275:103–107. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Melo Maia B, Lavorato-Rocha AM,
Rodrigues IS, Baiocchi G, Cestari FM, Stiepcich MM, Chinen LT,
Carvalho KC, Soares FA and Rocha RM: Prognostic significance of
c-KIT in vulvar cancer: Bringing this molecular marker from bench
to bedside. J Transl Med. 10:1502012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Marech I, Gadaleta CD and Ranieri G:
Possible prognostic and therapeutic significance of c-Kit
expression, mast cell count and microvessel density in renal cell
carcinoma. Int J Mol Sci. 15:13060–13076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yavuz AS, Lipsky PE, Yavuz S, Metcalfe DD
and Akin C: Evidence for the involvement of a hematopoietic
progenitor cell in systemic mastocytosis from single-cell analysis
of mutations in the c-kit gene. Blood. 100:661–665. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mora Vidal R, Regufe da Mota S, Hayden A,
Markham H, Douglas J, Packham G and Crabb SJ: Epidermal growth
factor receptor family inhibition identifies p38 Mitogen-activated
protein kinase as a potential therapeutic target in bladder cancer.
Urology. 112:225.e1–225.e7. 2018. View Article : Google Scholar
|
|
31
|
Lim MJ, Seo YH, Choi KJ, Cho CH, Kim BS,
Kim YH, Lee J, Lee H, Jung CY, Ha J, et al: Suppression of c-Src
activity stimulates muscle differentiation via p38 MAPK activation.
Arch Biochem Biophys. 465:197–208. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan C, Olsen JV, Daub H and Mann M: Global
effects of kinase inhibitors on signaling networks revealed by
quantitative phosphoproteomics. Mol Cell Proteomics. 8:2796–2808.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu W, Kovacevic Z, Peng Z, Jin R, Wang P,
Yue F, Zheng M, Huang ML, Jansson PJ, Richardson V, et al: The
molecular effect of metastasis suppressors on Src signaling and
tumorigenesis: new therapeutic targets. Oncotarget. 6:35522–35541.
2015.PubMed/NCBI
|
|
34
|
Johnson FM, Saigal B, Talpaz M and Donato
NJ: Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses
invasion and induces cell cycle arrest and apoptosis of head and
neck squamous cell carcinoma and non-small cell lung cancer cells.
Clin Cancer Res. 11:6924–6932. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Carlson JA, Linette GP, Aplin A, Ng B and
Slominski A: Melanocyte receptors: Clinical implications and
therapeutic relevance. Dermatol Clin. 25:541–ix. 2007. View Article : Google Scholar : PubMed/NCBI
|
